STOCK TITAN
  1. Home
  2. Sec-filings
  3. FRPT
  4. [Form 4] Freshpet, Inc. Insider Trading Activity

FRPT Form 4: Director Timothy McLevish acquires 3,500 shares at $56

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) director Timothy R. McLevish purchased 3,500 shares of common stock on 09/10/2025 at a price of $56 per share. After the transaction he beneficially owned 35,290 shares. The Form 4 was signed by an attorney-in-fact on 09/11/2025. The filing indicates the ownership is direct.

Positive

  • Director executed a purchase of common stock (3,500 shares) which is clearly documented on Form 4
  • Post-transaction ownership is disclosed (35,290 shares), providing transparency about insider holdings
  • Filing executed by attorney-in-fact with signature and date (09/11/2025), meeting procedural requirements

Negative

  • None.

Insights

TL;DR Director purchased 3,500 shares at $56, increasing direct holdings to 35,290 shares.

The reported transaction is a straightforward open-market purchase by a director, documented on Form 4 with clear quantities and price. The size of the trade (3,500 shares) and resulting total holdings are explicitly stated in the filing. No derivative transactions or additional disclosures are included.

TL;DR Filing shows a routine director stock acquisition reported under Section 16.

The Form 4 identifies the reporting person as a director and records a direct acquisition. The document is properly executed by an attorney-in-fact and includes the required transaction details and post-transaction beneficial ownership. There are no amendments, option grants, or indirect ownership claims in this filing.

Insider MCLEVISH TIMOTHY R
Role Director
Bought 3,500 shs ($196K)
Type Security Shares Price Value
Purchase Common Stock 3,500 $56.00 $196K
Holdings After Transaction: Common Stock — 35,290 shares (Direct)
Footnotes (1)
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCLEVISH TIMOTHY R
(Last) (First) (Middle)
C/O FRESHPET, INC.
1450 US-206
(Street)
BEDMINSTER NJ 07921
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/10/2025 P 3,500 A $56 35,290 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Lisa A. Alexander, as Attorney-in-fact for the Reporting Person 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What transaction did Timothy R. McLevish report on Form 4 for FRPT?

He reported a purchase of 3,500 shares of Freshpet common stock on 09/10/2025 at $56 per share.

How many Freshpet shares did McLevish own after the reported transaction?

The filing states he beneficially owned 35,290 shares following the transaction.

What is the reporting person's relationship to Freshpet, Inc. (FRPT)?

The Form 4 identifies Timothy R. McLevish as a Director of Freshpet, Inc.

Was the Form 4 signed and when?

Yes. The form shows a signature by an attorney-in-fact dated 09/11/2025.

Did the filing report any derivative transactions or option activity?

No. Table II for derivative securities contains no reported transactions in this filing.